Monoclonal antibodies against SARS-CoV-2: current scenario and future perspectives
E Quiros-Roldan, S Amadasi, I Zanella, M Degli Antoni… - Pharmaceuticals, 2021 - mdpi.com
Monoclonal antibodies (mAbs) have been known since the 1970s. However, their
therapeutic potential in the medical field has recently emerged, with the advancement of …
therapeutic potential in the medical field has recently emerged, with the advancement of …
Monoclonal antibodies as potential COVID-19 therapeutic agents
J Plichta, P Kuna, M Panek - COVID, 2022 - mdpi.com
The COVID-19 pandemic continues to cause tremendous loss of life and put massive strain
on the functioning of societies worldwide. Despite the cataclysmic proportions of this viral …
on the functioning of societies worldwide. Despite the cataclysmic proportions of this viral …
[HTML][HTML] Exploring the potential of broadly neutralizing antibodies for treating SARS-CoV-2 variants of global concern in 2023: a comprehensive clinical review
In the aftermath of the coronavirus disease 2019 (COVID-19) pandemic, the world is still
seeing outbreaks of COVID-19 infections as of 2023, especially in populations that have …
seeing outbreaks of COVID-19 infections as of 2023, especially in populations that have …
Therapeutic monoclonal antibodies for COVID-19 management: an update
VP Chavda, R Prajapati, D Lathigara… - Expert opinion on …, 2022 - Taylor & Francis
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
affected more than 529 million people, and today the world is facing different mutant strains …
affected more than 529 million people, and today the world is facing different mutant strains …
Status and Developing Strategies for Neutralizing Monoclonal Antibody Therapy in the Omicron Era of COVID-19
Z Ren, C Shen, J Peng - Viruses, 2023 - mdpi.com
The monoclonal antibody (mAb)-based treatment is a highly valued therapy against COVID-
19, especially for individuals who may not have strong immune responses to the vaccine …
19, especially for individuals who may not have strong immune responses to the vaccine …
[HTML][HTML] Monoclonal antibodies as COVID-19 prophylaxis therapy in immunocompromised patient populations
The objective of this review was to examine the latest literature regarding the effectiveness
of monoclonal antibodies as COVID-19 prophylaxis therapy for immunocompromised patient …
of monoclonal antibodies as COVID-19 prophylaxis therapy for immunocompromised patient …
Extremely potent human monoclonal antibodies from convalescent Covid-19 patients
Human monoclonal antibodies are safe, preventive and therapeutic tools, that can be rapidly
developed to help restore the massive health and economic disruption caused by the Covid …
developed to help restore the massive health and economic disruption caused by the Covid …
COVID-19 pandemic: vaccine and new monoclonal antibodies, point of view
A Vitiello, RL Porta, L Pianesi, F Ferrara - Irish Journal of Medical Science …, 2022 - Springer
The COVID-19 pandemic is the most serious health emergency of the twenty-first century, to
date causing approximately 106 million people to be infected and 2.32 million deaths …
date causing approximately 106 million people to be infected and 2.32 million deaths …
[PDF][PDF] Viewpoint on monoclonal antibody therapy: Advances in COVID-19 treatment
Background: With the number of Coronavirus Disease 2019 (COVID-19) cases on the rise
around the world, monoclonal antibodies (mAb) remain a feasible treatment option for …
around the world, monoclonal antibodies (mAb) remain a feasible treatment option for …
The relevance of monoclonal antibodies in the treatment of COVID-19
A Torrente-López, J Hermosilla, N Navas… - Vaccines, 2021 - mdpi.com
Major efforts have been made in the search for effective treatments since the outbreak of the
COVID-19 infection in December 2019. Extensive research has been conducted on drugs …
COVID-19 infection in December 2019. Extensive research has been conducted on drugs …